BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 22851953)

  • 1. Secondary leukemia associated with the anti-cancer agent, etoposide, a topoisomerase II inhibitor.
    Ezoe S
    Int J Environ Res Public Health; 2012 Jul; 9(7):2444-53. PubMed ID: 22851953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etoposide and illegitimate DNA double-strand break repair in the generation of MLL translocations: new insights and new questions.
    Sung PA; Libura J; Richardson C
    DNA Repair (Amst); 2006 Sep; 5(9-10):1109-18. PubMed ID: 16809075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ALL-1 gene rearrangements in DNA topoisomerase II inhibitor-related leukemia in children.
    Felix CA; Hosler MR; Winick NJ; Masterson M; Wilson AE; Lange BJ
    Blood; 1995 Jun; 85(11):3250-6. PubMed ID: 7756657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etoposide sensitivity does not predict MLL rearrangements or risk of therapy-related acute myeloid leukemia.
    Yang J; Bogni A; Cheng C; Bleibel WK; Cai X; Fan Y; Yang W; Rocha JC; Pei D; Liu W; Dolan ME; Pui CH; Relling MV
    Clin Pharmacol Ther; 2008 Dec; 84(6):691-7. PubMed ID: 18509329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of generation of therapy related leukemia in response to anti-topoisomerase II agents.
    Cowell IG; Austin CA
    Int J Environ Res Public Health; 2012 Jun; 9(6):2075-91. PubMed ID: 22829791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy-related - late occurring - Philadelphia chromosome in AML, ALL and CML. Similar events related to treatment with DNA topoisomerase II inhibitors?
    Pedersen-Bjergaard J; Brøndum-Nielsen K; Karle H; Johansson B
    Leukemia; 1997 Sep; 11(9):1571-4. PubMed ID: 9305614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary acute myeloid leukemia after etoposide therapy for haemophagocytic lymphohistiocytosis.
    RamaChandran S; Ariffin H
    Pediatr Blood Cancer; 2009 Sep; 53(3):488-90. PubMed ID: 19434733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute myeloid leukemia following etoposide therapy for EBV-associated hemophagocytic lymphohistiocytosis: a case report and a brief review of the literature.
    Pan H; Feng DN; Song L; Sun LR
    BMC Pediatr; 2016 Jul; 16():116. PubMed ID: 27473573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MLL/AF-1p fusion in therapy-related early pre-B acute lymphoblastic leukemia with t(1;11)(p32;q23) translocation developing in the relapse phase of acute promyelocytic leukemia.
    Tsujioka T; Wada H; Yamamori S; Otsuki T; Suemori S; Kondo T; Nakanishi H; Suetsugu Y; Mikami M; Sugihara T
    Int J Hematol; 2003 Dec; 78(5):439-42. PubMed ID: 14704037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy-related acute leukemia associated with t(11q23) after primary acute myeloid leukemia with t(8;21): a report of two cases.
    Roulston D; Anastasi J; Rudinsky R; Nucifora G; Zeleznik-Le N; Rowley JD; McGavran L; Tsuchida M; Hayashi Y
    Blood; 1995 Nov; 86(9):3613-4. PubMed ID: 7579475
    [No Abstract]   [Full Text] [Related]  

  • 11. Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA-topoisomerase II.
    Super HJ; McCabe NR; Thirman MJ; Larson RA; Le Beau MM; Pedersen-Bjergaard J; Philip P; Diaz MO; Rowley JD
    Blood; 1993 Dec; 82(12):3705-11. PubMed ID: 8260707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MLL rearrangements are induced by low doses of etoposide in human fetal hematopoietic stem cells.
    Moneypenny CG; Shao J; Song Y; Gallagher EP
    Carcinogenesis; 2006 Apr; 27(4):874-81. PubMed ID: 16377807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of 11q23 breakpoints within the MLL breakpoint cluster region in de novo acute leukemia and in treatment-related acute myeloid leukemia: correlation with scaffold attachment regions and topoisomerase II consensus binding sites.
    Broeker PL; Super HG; Thirman MJ; Pomykala H; Yonebayashi Y; Tanabe S; Zeleznik-Le N; Rowley JD
    Blood; 1996 Mar; 87(5):1912-22. PubMed ID: 8634439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular analysis of 13 cases of MLL/11q23 secondary acute leukemia and identification of topoisomerase II consensus-binding sequences near the chromosomal breakpoint of a secondary leukemia with the t(4;11).
    Domer PH; Head DR; Renganathan N; Raimondi SC; Yang E; Atlas M
    Leukemia; 1995 Aug; 9(8):1305-12. PubMed ID: 7643617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Model for MLL translocations in therapy-related leukemia involving topoisomerase IIβ-mediated DNA strand breaks and gene proximity.
    Cowell IG; Sondka Z; Smith K; Lee KC; Manville CM; Sidorczuk-Lesthuruge M; Rance HA; Padget K; Jackson GH; Adachi N; Austin CA
    Proc Natl Acad Sci U S A; 2012 Jun; 109(23):8989-94. PubMed ID: 22615413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy-related acute myeloid leukemia-like MLL rearrangements are induced by etoposide in primary human CD34+ cells and remain stable after clonal expansion.
    Libura J; Slater DJ; Felix CA; Richardson C
    Blood; 2005 Mar; 105(5):2124-31. PubMed ID: 15528316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapy-Related Acute Myeloid Leukemia Following Etoposide Based Chemotherapy in Germ Cell Tumor].
    Okumura Y; Oae M; Shiraishi Y; Soda T; Kanamaru H; Arima N
    Hinyokika Kiyo; 2016 May; 62(5):271-4. PubMed ID: 27320120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy-related leukemia and myelodysplasia following oral administration of etoposide for recurrent breast cancer.
    Yagita M; Ieki Y; Onishi R; Huang CL; Adachi M; Horiike S; Konaka Y; Taki T; Miyake M
    Int J Oncol; 1998 Jul; 13(1):91-6. PubMed ID: 9625808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Site-specific DNA cleavage within the MLL breakpoint cluster region induced by topoisomerase II inhibitors.
    Aplan PD; Chervinsky DS; Stanulla M; Burhans WC
    Blood; 1996 Apr; 87(7):2649-58. PubMed ID: 8639880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral etoposide in relapsed or refractory Ewing sarcoma: a monoinstitutional experience in children and adolescents.
    Podda MG; Luksch R; Puma N; Gandola L; Morosi C; Terenziani M; Ferrari A; Casanova M; Spreafico F; Meazza C; Catania S; Schiavello E; Biassoni V; Chiaravalli S; Massimino M
    Tumori; 2016; 102(1):84-8. PubMed ID: 26797935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.